Related Experiment Video
Updated: Aug 18, 2026

Evaluation of Mammary Gland Development and Function in Mouse Models
Published on: July 21, 2011
Changes in the prolactin-binding capacity of mouse hepatic membranes with development and aging
Abstract:
The objective of this study was to document the developmental changes in the prolactin-binding capacity of hepatic membranes of the female mouse. Prolactin-binding capacity was measured in the microsomal membranes of liver obtained from C3H female mice at various ages. Binding capacity of these membranes remained low until 21 days of age after which it increased and reached the adult levels by 44 days of age. Additional studies were made to observe this parameter in male and female mice during aging. Both female and male mice at 450-470 days of age had values of prolactin binding that were 66% and 79% that of the 77-day-old animals, respectively. A significant increase in membrane lipid microviscosity was observed in animals from both sexes at 450-470 days of age. This was in agreement with earlier studies that showed that prolactin receptors of hepatic membranes are modulated by changes in the membrane lipid microviscosity. These changes suggest that such modifications of cellular membranes are interrelated and that changes in the membrane microviscosity with aging may be a factor modulating cellular responses in older animals.
More Related Videos
09:29Isolation of Intermediate Filament Proteins from Multiple Mouse Tissues to Study Aging-associated Post-translational Modifications
Published on: May 18, 2017
09:15Reproducible Setup for In vivo Two-photon Imaging of the Contractility of Cervical Lymphatic Vessels and Lymph Flow in Mice
Published on: April 10, 2026
Related Concept Videos
Factors Affecting Protein-Drug Binding: Patient-Related Factors
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Pharmacodynamics in Geriatric Patients: Effects of Age
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test